Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III–IV malignant melanoma

The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Wallace H. Clark, Lynn From, Evelina A. Bernardino et al. · PubMed · 1969 · 2.1K citations

Medicine, Dermatology, Pathology +17

A new American Joint Committee on Cancer staging system for cutaneous melanoma

Charles M. Balch, Antônio C. Buzaid, Michael B. Atkins et al. · Cancer · 2000 · 426 citations

Medicine, Dermatology, Oncology +17

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

Antônio C. Buzaid, Merrick I. Ross, Charles M. Balch et al. · Journal of Clinical Oncology · 1997 · 303 citations

Medicine, Dermatology, Oncology +17

S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma

Martin Deichmann, Axel Benner, Michael Bock et al. · Journal of Clinical Oncology · 1999 · 229 citations

Medicine, Clinical Sciences, Oncology +17

Clinical significance of serum S100 in metastatic malignant melanoma

Hua Guo, Birgit Stoffel‐Wagner, T. Bierwirth et al. · European Journal of Cancer · 1995 · 157 citations

Medicine, Oncology, Pathology +16